Literature DB >> 27839921

Assessment of insulin sensitivity by the hyperinsulinemic euglycemic clamp: Comparison with the spectral analysis of photoplethysmography.

Aglecio Luiz De Souza1, Gisele Almeida Batista2, Sarah Monte Alegre2.   

Abstract

AIMS: We compare spectral analysis of photoplethysmography (PTG) with insulin resistance measured by the hyperinsulinemic euglycemic clamp (HEC) technique. MATERIAL AND
METHOD: A total of 100 nondiabetic subjects, 43 men and 57 women aged 20-63years, 30 lean, 42 overweight and 28 obese were enrolled in the study. These patients underwent an examination with HEC, and an examination with the PTG spectral analysis and calculation of the PTG Total Power (PTG-TP). Receiver-operating characteristic (ROC) curves were constructed to determine the specificity and sensitivity of PTG-TP in the assessment of insulin resistance.
RESULTS: There is a moderate correlation between insulin sensitivity (M-value) and PTG-TP (r=- 0.64, p<0.0001). The ROC curves showed that the most relevant cutoff to the whole study group was a PTG-TP>406.2. This cut-off had a sensitivity=95.7%, specificity =84,4% and the area under the ROC curve (AUC)=0.929 for identifying insulin resistance. All AUC ROC curve analysis were significant (p<0.0001).
CONCLUSION: The use of the PTG-TP marker measured from the PTG spectral analysis is a useful tool in screening and follow up of IR, especially in large-scale studies.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Hyperinsulinemic euglycemic clamp; Insulin resistance; Photoplethysmography; ROC curve

Mesh:

Substances:

Year:  2016        PMID: 27839921     DOI: 10.1016/j.jdiacomp.2016.10.018

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  6 in total

1.  Antihyperglycemic and Antihyperlipidemic Activity of Hydroponic Stevia rebaudiana Aqueous Extract in Hyperglycemia Induced by Immobilization Stress in Rabbits.

Authors:  Anush Aghajanyan; Zaruhi Movsisyan; Armen Trchounian
Journal:  Biomed Res Int       Date:  2017-07-03       Impact factor: 3.411

2.  New method of sudomotor function measurement to detect microvascular disease and sweat gland nerve or unmyelinated C fiber dysfunction in adults with retinopathy.

Authors:  John E Lewis; Steven E Atlas; Ammar Rasul; Ashar Farooqi; Laura Lantigua; Oscar L Higuera; Andrea Fiallo; Lianette Laria; Renata Picciani; Ken Wals; Zohar Yehoshua; Armando Mendez; Janet Konefal; Sharon Goldberg; Judi Woolger
Journal:  J Diabetes Metab Disord       Date:  2017-06-12

3.  Cardiovascular, endothelial function, and immune markers in response to treatment with a polysaccharide in HIV+ adults in a randomized, double-blind placebo-controlled trial.

Authors:  John E Lewis; Steven E Atlas; Muhammad H Abbas; Ammar Rasul; Ashar Farooqi; Laura A Lantigua; Frederick Michaud; Sharon Goldberg; Lucas C Lages; Jinrun Gao; Oscar L Higuera; Andrea Fiallo; Philip D Harvey; Eduard Tiozzo; Judi M Woolger; Stephanie Ciraula; Armando Mendez; Allan Rodriguez; Janet Konefal
Journal:  J Clin Transl Res       Date:  2020-04-13

4.  Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement.

Authors:  Alejandro Rosell Castillo; Aglecio Luiz de Souza; Sarah Monte Alegre; Yeelen Ballesteros Atala; Denise Engelbrecht Zantut-Wittmann; Heraldo Mendes Garmes
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-07       Impact factor: 5.555

5.  Triglyceride-Glucose Index Correlate With Telomere Length in Healthy Adults From the National Health and Nutrition Examination Survey.

Authors:  Lihua Hu; Qiaojian Zhang; Yi Bai; Guiping Hu; Jianping Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

6.  Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome.

Authors:  M Mirr; D Skrypnik; P Bogdański; M Owecki
Journal:  J Endocrinol Invest       Date:  2021-06-16       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.